Evaluation Of Mass Drug Administration Programme For Elimination Of Lymphatic Filariasis In Kalburgi District, Karnataka
DOI:
https://doi.org/10.37506/z0e6xx10Keywords:
Lymphatic filariasis, Mass drug administration, Coverage, Compliance, Diethylcarbamazine, Kalaburgi.Abstract
Background: Lymphatic Filariasis (LF) is endemic in 83 countries and territories, with more than a billion people at risk of infection. Filariasis has been a major public health problem in India next only to Malaria. Present study was done to assess coverage and compliance of mass drug administration (MDA) against lymphatic Filariasis in Kalaburgi district.
Methods: A coverage evaluation survey was done in one urban and three rural clusters in Kalaburgi district. The data was compiled, tabulated and analyzed using proportions.
Results: Among total of 683 subjects who were interviewed, 54.61%. were male subjects and only 406 (62.08% )of the participants have received the drugs. Out of the 406 persons who have received the drugs, 76.6% persons have consumed the drugs. Only 3.54% of study subjects consumed tablets in front of health workers. A total of 277 subjects did not consume the tablets.The reasons for non consumption of tablets were , 66.06% told drug distributor did not visit, 8.3% said that they were out of station and 7.94% subjects were not aware. Among the total only 9 persons suffered from nausea and vomiting.
Conclusions: There is an urgent need for more effective drug delivery strategies and also proper IEC should be done to educate and to improve the coverage and compliance in the districts.
References
Krentel A, Fischer P, Manoempil P, Supali T, Servais G, Rückert P. Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia. Trop Med Int Health. 2006;11:1731-40.
World Health Organization. Life in the 21 st century: A vision for all. The World Health Report 1998. Available at: http://www.who.int/whr/1998/en/whr98 en.pdf. Accessed on 29 April 2017.
World Health Organization. Regional strategic plan for elimination of Lymphatic Filariasis (2004-2007) 2004; 1-2. Available at: apps.searo.who.int/pdsdocs/B0207.pdf. Accessed on 30 April 2017.
. Das PK, Ramaiah KD, Augustine DJ, Kumar A. Towards elimination of lymphatic filariasis in India. Trends Parasitol. 2001;17:457–60.
Savioli L, Crompton DWT, Ottesen EA, Montresor A, Hayashi S. Intestinal worms beware: development in antihelminthic chemotherapy usage. Parasitol Today. 1997;13:43–4.
Ottesen EA, Ismail MM, Horton J. The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today. 1999;15:382-6.
National Health Policy 2002. New Delhi: Ministry of Health and Family Welfare, Government of India 2002: 1-39.
World Health Organization. Preparing and implementing a national plan to eliminate Lymphatic filariasis in countries where Onchocerciasis is not co-endemic. Available at: http://whqlibdoc.who.int/hq/2000/WHO_CDS_CPE_CEE_2000.15.pdf. Accessed on 25 April 2017.
El Setouhy M, Ramzy RM, Ahmed ES, Kandil AM, Hussain O, Farid HA, et al. A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftianfilariasis. Am J Trop Med Hyg. 2004;70:191-6.
Dogara M, Nock H, Agbede R, Ndams S, Joseph K. Entomological survey of mosquitoes responsible for the transmission of Lymphatic Filariasis in three endemic villages of Kano State, Nigeria. Int J WorldHealth Societal Politics. 2012;7:2:1-6.
Patel PK. Mass drug administration coverage evaluation survey for lymphatic Filariasis in Bagalkot and Gulbarga districts. Indian J Community Med. 2012;37:101-6.
Mukhopadhyay AK, Patnaik SK, SatyaBabu P, Rao KNMB. Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India. J Vector Borne Dis. 2008;45:73–5.
Babu BV, Kar SK. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India. Tropical Med Int Health. 2004;9(6):702–9.
Lahariya C, Mishra A. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study. J Vector Borne Dis. 2008;45:313–20.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Mahesh S Hoolageri, Rajashree Kotabal, Kruthika K, Jayashree K S
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.